471 related articles for article (PubMed ID: 15293705)
41. Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
Bedikian AY; Johnson MM; Warneke CL; Papadopoulos NE; Kim K; Hwu WJ; McIntyre S; Hwu P
Cancer Invest; 2008 Jul; 26(6):624-33. PubMed ID: 18584354
[TBL] [Abstract][Full Text] [Related]
42. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
Vollmer RT; Seigler HF
Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
[TBL] [Abstract][Full Text] [Related]
43. Multidisciplinary treatment of primary melanoma.
Yao K; Balch G; Winchester DJ
Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
[TBL] [Abstract][Full Text] [Related]
44. Management of early-stage cutaneous melanoma.
Aloia TA; Gershenwald JE
Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
[No Abstract] [Full Text] [Related]
45. Surgical management of melanoma.
Wargo JA; Tanabe K
Hematol Oncol Clin North Am; 2009 Jun; 23(3):565-81, x. PubMed ID: 19464603
[TBL] [Abstract][Full Text] [Related]
46. Gastrointestinal metastases of cutaneous melanoma.
La Torre M; Frezza B; Fransvea P; Ziparo V; Balducci G; Costa G
Am Surg; 2014 Feb; 80(2):E45-6. PubMed ID: 24480197
[No Abstract] [Full Text] [Related]
47. New trends in the treatment of malignant melanoma.
Veronesi U; Bajetta E; Cascinelli N; Clemente C; Rilke F
Int Adv Surg Oncol; 1978; 1():113-56. PubMed ID: 399762
[No Abstract] [Full Text] [Related]
48. [Pathomorphosis of metastatic malignant melanoma of the skin as effected by preoperative endolymphatic polychemotherapy].
Naleskina LA; Tolstopiatov BA; Korovin SI
Klin Khir (1962); 1993; (5):27-30. PubMed ID: 7933857
[TBL] [Abstract][Full Text] [Related]
49. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Gimotty PA; Guerry D; Flaherty K
J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111
[No Abstract] [Full Text] [Related]
50. [Malignant melanoma. Prognostic factors].
Schnyder UW
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):453-5. PubMed ID: 3375670
[No Abstract] [Full Text] [Related]
51. Melanoma in the elderly patient: relevance of the aging immune system.
Hegde UP; Chakraborty N; Kerr P; Grant-Kels JM
Clin Dermatol; 2009; 27(6):537-44. PubMed ID: 19880041
[TBL] [Abstract][Full Text] [Related]
52. Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
Vural F; Saydam G; Cagirgan S; Ertekin B; Hekimgil M; Unal I; Soydan S; Tombuloglu M
Int J Dermatol; 2008 Jul; 47(7):675-80. PubMed ID: 18613872
[No Abstract] [Full Text] [Related]
53. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
54. [Clinical aspects and prognosis of malignant melanoma].
Heite HJ
Haematol Blood Transfus; 1978; 21():233-47. PubMed ID: 738636
[No Abstract] [Full Text] [Related]
55. [Therapeutical options in malignant skin tumours].
Stanisz H; Tilgen W; Rass K
MMW Fortschr Med; 2009 Sep; 151(39):34-8. PubMed ID: 19831193
[No Abstract] [Full Text] [Related]
56. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
Ferrari A; Bono A; Baldi M; Collini P; Casanova M; Pennacchioli E; Terenziani M; Marcon I; Santinami M; Bartoli C
Pediatrics; 2005 Mar; 115(3):649-54. PubMed ID: 15741367
[TBL] [Abstract][Full Text] [Related]
57. Impact of thorough block sampling in the histologic evaluation of melanomas.
Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
[TBL] [Abstract][Full Text] [Related]
58. [Malignant melanoma of the skin].
Simon JC; Grimme H; Bergen E; Vanscheidt W; Schöpf E
Fortschr Med; 1995 Oct; 113(28):393-6. PubMed ID: 7498864
[TBL] [Abstract][Full Text] [Related]
59. Immunotherapy for the management of advanced melanoma: the next steps.
Zikich D; Schachter J; Besser MJ
Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors in melanoma outcome and survival.
Le TT; Pitman KT
Facial Plast Surg Clin North Am; 2003 Feb; 11(1):33-41. PubMed ID: 15062285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
